Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Inflammatory Breast Cancer (IBC)
Interventions: DRUG: Ruxolitinib|DRUG: Paclitaxel|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: Dana-Farber Cancer Institute
Collaborators: Incyte Corporation